tetano
Editor, Senior Moderator
J Med Virol
. 2022 Nov 29.
doi: 10.1002/jmv.28359. Online ahead of print.
The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection
Deyan Luo[SUP] 1 [/SUP], Tao Li[SUP] 1 [/SUP], Xiaolan Yang[SUP] 1 [/SUP], Nianzhi Ning[SUP] 1 [/SUP], Liangyan Zhang[SUP] 1 [/SUP], Hongjing Gu[SUP] 1 [/SUP], Deyu Li[SUP] 1 [/SUP], Wenjing Yu[SUP] 1 [/SUP], Zhongyu Hu[SUP] 2 [/SUP], Hui Wang[SUP] 1 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel subset of coronavirus that causes coronavirus disease 2019 (COVID-19), but vaccine development is hampered by the high mutation of virus This article is protected by copyright. All rights reserved.
Keywords: Disease control; Immune responses; SARS coronavirus; Vaccines/Vaccine strains; Virus classification.
. 2022 Nov 29.
doi: 10.1002/jmv.28359. Online ahead of print.
The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection
Deyan Luo[SUP] 1 [/SUP], Tao Li[SUP] 1 [/SUP], Xiaolan Yang[SUP] 1 [/SUP], Nianzhi Ning[SUP] 1 [/SUP], Liangyan Zhang[SUP] 1 [/SUP], Hongjing Gu[SUP] 1 [/SUP], Deyu Li[SUP] 1 [/SUP], Wenjing Yu[SUP] 1 [/SUP], Zhongyu Hu[SUP] 2 [/SUP], Hui Wang[SUP] 1 [/SUP]
Affiliations
- PMID: 36448090
- DOI: 10.1002/jmv.28359
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel subset of coronavirus that causes coronavirus disease 2019 (COVID-19), but vaccine development is hampered by the high mutation of virus This article is protected by copyright. All rights reserved.
Keywords: Disease control; Immune responses; SARS coronavirus; Vaccines/Vaccine strains; Virus classification.